Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:03:13.770Z.
Calculation as of: 2026-10-06T17:03:13.770Z.
Quote observation: 2026-10-06T17:00:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fb4a8502ebbb15e11e68a15a33f7d53c7b5c9812bb79594c7d74d11368e8432a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Milestone Pharmaceuticals Inc.
Market Cap
$97.61M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.00M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.25M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.67M
Free Cash Flow Yield
4.12%
TTM Avg
1.81%
3Y Avg
3.57%
5Y Avg
3.20%
Market Cap
$91.25M
Free Cash Flow Yield
5445.61%
TTM Avg
1623.44%
3Y Avg
1623.44%
5Y Avg
1623.44%
Market Cap
$104.68M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $97.61M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.49M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.04M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.00M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.25M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $102.67M | 4.12% | 1.81% | 3.57% | 3.20% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.30M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $91.25M | 5445.61% | 1623.44% | 1623.44% | 1623.44% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $90.73M | N/A | 23.21% | 23.21% | 23.21% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
